Clinical Trial Update: A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas [Phase 1]

View source ↗

Summary

This document provides an update on a Phase I trial evaluating Enzastaurin in combination with Carboplatin for adults with recurrent gliomas, noting the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Recurrent Gliomas | Phase 1 | Status: COMPLETED